Introduction Primary membranous nephropathy (PMN) is associated with the anti-
phospholipase A2 receptor (anti-PLA2R) antibody in 70% of cases. Some anti-PLA2R …

Autoantibody formation directed against phospholipase A2 receptor (PLA2R) 1 is the
underlying etiology in most cases of primary membranous glomerulopathy. This new …

Autoantibodies against phospholipase A2 receptor (PLA2R) are a sensitive and specific
marker for idiopathic membranous nephropathy (IMN). The aim of our study was to redefine …

Objectives This study aimed to compare the performance of enzyme-linked immunosorbent
assay (ELISA) and magnetic particle chemiluminescence immunoassay (MP-CLIA) for …

The phospholipase A2 receptor 1 (PLA2R1) is the major target antigen in patients with
membranous nephropathy (MN), an antibody-mediated autoimmune glomerular disease …

Introduction Autoantibodies to M-type phospholipase A2 receptor (aPLA2R) are seen in two-
thirds of patients with primary membranous nephropathy (PMN) and are associated with …

Background: According to the renal phospholipase A2 receptor (PLA2R)
immunohistochemistry, idiopathic membranous nephropathy (iMN) could be categorized …

Background M-type phospholipase A2 receptor (PLA2R) and thrombospondin type-1
domain-containing 7A (THSD7A) have recently been identified as target antigens for …

Background To discuss the clinicopathological features and prognosis of patients with
idiopathic membranous nephropathy (IMN) who are serum-negative for the anti-PLA2R …

Abstract Phospholipase A 2 receptor 1 (PLA2R) is a target autoantigen in 70% of patients
with idiopathic membranous nephropathy. We describe the location of a major epitope in the …